CIK: 0001346824 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $5,935,681 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | ASCENDIS PHARMA A/S - ADR | 10,281,496 | $1,774,586 | 29.9% | $82.85 | — | SH | 04351P101 |
| PCVX | VAXCYTE INC | 11,965,991 | $389,014 | 6.6% | $51.21 | -36.0% | SH | 92243G108 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 5,561,359 | $351,422 | 5.9% | $25.92 | +136.2% | SH | 76243J105 |
| JANX | JANUX THERAPEUTICS INC | 11,189,693 | $258,482 | 4.4% | $26.21 | +0.5% | SH | 47103J105 |
| RNAM | AVIDITY BIOSCIENCES INC | 7,266,031 | $206,355 | 3.5% | $25.22 | +18.2% | SH | 05370A108 |
| ACLX | ARCELLX INC | 3,036,527 | $199,955 | 3.4% | $66.33 | -6.1% | SH | 03940C100 |
| — | 89BIO INC | 19,889,683 | $195,317 | 3.3% | $12.96 | — | SH | 282559103 |
| SPRY | ARS PHARMACEUTICALS INC | 10,860,977 | $189,524 | 3.2% | $6.66 | +116.7% | SH | 82835W108 |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 10,138,938 | $183,616 | 3.1% | $14.02 | +30.1% | SH | N62509109 |
| SION | SIONNA THERAPEUTICS INC | 10,445,322 | $181,226 | 3.1% | $16.34 | -19.8% | SH | 829401108 |
| — | CIDARA THERAPEUTICS INC | 3,365,523 | $163,935 | 2.8% | $38.25 | — | SH | 171757206 |
| EWTX | EDGEWISE THERAPEUTICS INC | 9,902,633 | $129,824 | 2.2% | $15.75 | -8.4% | SH | 28036F105 |
| LENZ | LENZ THERAPEUTICS INC | 4,178,823 | $122,481 | 2.1% | $20.79 | +30.9% | SH | 52635N103 |
| WVE | WAVE LIFE SCIENCES LTD | 18,202,009 | $118,313 | 2.0% | $8.66 | -23.8% | SH | Y95308105 |
| TYRA | TYRA BIOSCIENCES INC | 12,198,625 | $116,741 | 2.0% | $17.16 | -44.6% | SH | 90240B106 |
| GHRS | GH RESEARCH PLC | 7,676,697 | $93,579 | 1.6% | $15.85 | -30.8% | SH | G3855L106 |
| DYN | DYNE THERAPEUTICS INC | 9,714,392 | $92,481 | 1.6% | $21.08 | -47.8% | SH | 26818M108 |
| GERN | GERON CORP | 60,379,366 | $85,135 | 1.4% | $2.43 | -41.6% | SH | 374163103 |
| IRON | DISC MEDICINE INC | 1,577,106 | $83,524 | 1.4% | $55.60 | -15.5% | SH | 254604101 |
| MLYS | MINERALYS THERAPEUTICS INC | 6,147,280 | $83,173 | 1.4% | $14.49 | +0.0% | SH | 603170101 |
| SEPN | SEPTERNA INC | 6,995,858 | $73,946 | 1.2% | $23.65 | -65.2% | SH | 81734D104 |
| FULC | FULCRUM THERAPEUTICS INC | 10,229,099 | $70,376 | 1.2% | $7.35 | -27.2% | SH | 359616109 |
| BCAX | BICARA THERAPEUTICS INC | 6,955,993 | $64,621 | 1.1% | $25.50 | -53.3% | SH | 055477103 |
| — | VOR BIOPHARMA INC | 39,646,039 | $64,227 | 1.1% | $14.51 | — | SH | 929033108 |
| TSHA | TAYSHA GENE THERAPIES INC | 23,555,648 | $54,414 | 0.9% | $2.03 | +6.9% | SH | 877619106 |
| DNTH | DIANTHUS THERAPEUTICS INC | 2,866,733 | $53,407 | 0.9% | $21.84 | -14.1% | SH | 252828108 |
| RXST | RXSIGHT INC | 3,702,967 | $48,139 | 0.8% | $20.42 | -26.4% | SH | 78349D107 |
| — | TOURMALINE BIO INC | 2,538,925 | $40,597 | 0.7% | $12.86 | — | SH | 89157D105 |
| SRRK | SCHOLAR ROCK HOLDING CORP | 1,136,453 | $40,253 | 0.7% | $38.38 | -18.2% | SH | 80706P103 |
| CLYM | CLIMB BIO INC | 31,419,267 | $38,960 | 0.7% | $12.52 | -90.1% | SH | 28658R106 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,517,418 | $31,471 | 0.5% | $41.59 | — | SH | 86366E106 |
| SLDB | SOLID BIOSCIENCES INC | 5,811,323 | $28,301 | 0.5% | $6.22 | -43.2% | SH | 83422E204 |
| — | METSERA INC | 675,525 | $19,219 | 0.3% | $27.22 | — | SH | 59267L107 |
| MNPR | MONOPAR THERAPEUTICS INC | 511,207 | $18,291 | 0.3% | $16.78 | +116.4% | SH | 61023L207 |
| NKTX | NKARTA INC | 10,805,129 | $17,937 | 0.3% | $20.85 | -91.2% | SH | 65487U108 |
| LRMR | LARIMAR THERAPEUTICS INC | 6,045,351 | $17,471 | 0.3% | $7.79 | -70.3% | SH | 517125100 |
| ABOS | ACUMEN PHARMACEUTICALS INC | 14,932,063 | $17,321 | 0.3% | $13.02 | -91.7% | SH | 00509G209 |
| ELVN | ENLIVEN THERAPEUTICS INC | 848,986 | $17,031 | 0.3% | $20.34 | -6.9% | SH | 29337E102 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,150,000 | $17,020 | 0.3% | $17.69 | -6.3% | SH | 89422G107 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,563,211 | $16,930 | 0.3% | $19.29 | -81.8% | SH | 35104E100 |
| HNGE | HINGE HEALTH INC-A | 300,000 | $15,525 | 0.3% | $40.42 | 0.0% | SH | 433313103 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 9,853,302 | $14,878 | 0.3% | $11.59 | -81.9% | SH | 04317A107 |
| PEPG | PEPGEN INC | 10,689,545 | $11,865 | 0.2% | $11.31 | -87.5% | SH | 713317105 |
| JBIO | JADE BIOSCIENCES INC | 1,062,326 | $10,613 | 0.2% | $33.31 | 0.0% | SH | 008064206 |
| TNGX | TANGO THERAPEUTICS INC | 2,000,000 | $10,240 | 0.2% | $2.47 | 0.0% | SH | 87583X109 |
| ACRV | ACRIVON THERAPEUTICS INC | 8,340,508 | $9,925 | 0.2% | $10.73 | -87.2% | SH | 004890109 |
| ELDN | ELEDON PHARMACEUTICALS INC | 3,566,338 | $9,665 | 0.2% | $3.94 | -23.9% | SH | 28617K101 |
| RCUS | ARCUS BIOSCIENCES INC | 1,136,364 | $9,250 | 0.2% | $11.59 | -26.3% | SH | 03969F109 |
| PCSC | PERCEPTIVE CAPITAL SOLUTIONS | 750,000 | $7,965 | 0.1% | $10.07 | +3.8% | SH | G70077105 |
| OMDA | OMADA HEALTH INC | 400,000 | $7,320 | 0.1% | $17.31 | 0.0% | SH | 68170A108 |
| HOWL | WEREWOLF THERAPEUTICS INC | 6,681,307 | $7,283 | 0.1% | $9.71 | -89.4% | SH | 95075A107 |
| BBNX | BETA BIONICS INC | 500,000 | $7,280 | 0.1% | $18.64 | -24.1% | SH | 08659B102 |
| CTMX | CYTOMX THERAPEUTICS INC | 2,661,331 | $6,041 | 0.1% | $1.30 | +24.2% | SH | 23284F105 |
| TXG | 10X GENOMICS INC-CLASS A | 475,343 | $5,504 | 0.1% | $15.78 | -42.2% | SH | 88025U109 |
| SRZN | SURROZEN INC | 602,626 | $5,387 | 0.1% | $11.08 | -17.5% | SH | 86889P208 |
| WGS | GENEDX HOLDINGS CORP | 58,044 | $5,358 | 0.1% | $78.50 | 0.0% | SH | 81663L200 |
| AVTX | AVALO THERAPEUTICS INC | 932,973 | $4,656 | 0.1% | $10.31 | -54.7% | SH | 05338F306 |
| — | ADICET BIO INC | 7,541,000 | $4,600 | 0.1% | $2.35 | — | SH | 007002108 |
| MBX | MBX BIOSCIENCES INC | 377,841 | $4,311 | 0.1% | $22.87 | -55.5% | SH | 55287L101 |
| TARA | PROTARA THERAPEUTIC INC | 1,039,295 | $3,149 | 0.1% | $3.06 | +12.8% | SH | 74365U107 |
| NAMSW | NEWAMSTERDAM PHARMA CO NV-27 | 333,333 | $2,667 | 0.0% | $0.87 | — | SH | N62509117 |
| ACHC | ACADIA HEALTHCARE CO INC | 89,262 | $2,025 | 0.0% | $38.10 | -37.8% | SH | 00404A109 |
| IFRX | INFLARX NV | 1,973,233 | $1,559 | 0.0% | $1.18 | 0.0% | SH | N44821101 |